c'est officiel

Arena Pharmaceuticals Inc. on Sunday said the Food and Drug Administration rejected the company's application for lorcaserin, one of three drugs seeking to become the first new FDA-approved prescription weight loss drug in more than a decade.

The company plans to hold a conference call on Monday to discuss the FDA's rejection. Arena President and CEO Jack Lief said in a news release that his company plans to request a meeting with the FDA "to obtain further clarity on the approval path and timeline."